NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

8302	Companies
115165	Keywords
55486	Articles
62551	Press releases

Home
Companies
NanoViricides, Inc.

PRESS RELEASE

published on 06/11/2024 at 12:30, 5 months 10 days ago

Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
NanoViricides, Inc. reports positive results of broad-spectrum antiviral drug NV-387 in animal models, showing sustained antiviral effect with extended flat blood concentration profile upon oral administration

NV-387 Broad-spectrum Antiviral Drug NanoViricides Inc Animal Models Oral Administration
BRIEF

published on 06/04/2024 at 12:35, 5 months 17 days ago

Le profil de concentration sanguine soutenu du NV-387 permet un dosage peu fréquent

NanoViricides NV-387 Antiviral À Large Spectre Traitement Du VRS Et Du COVID-19 Dosage Peu Fréquent
BRIEF

published on 06/04/2024 at 12:35, 5 months 17 days ago

Sustained Blood Concentration Profile of NV-387 Allows Infrequent Dosing

NanoViricides NV-387 Broad-spectrum Antiviral RSV And COVID-19 Treatment Infrequent Dosing
PRESS RELEASE

published on 06/04/2024 at 12:30, 5 months 17 days ago

The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
NanoViricides, Inc. reports positive pharmacokinetic profile of NV-387 in non-human primate model, showcasing sustained blood concentrations enabling less frequent dosing for its broad-spectrum antiviral agent. The unique polymeric design supports potential against RSV, COVID, and influenza

NV-387 NanoViricides Inc. Broad-spectrum Antiviral Agent Pharmacokinetic Profile RSV COVID Influenza
BRIEF

published on 05/29/2024 at 12:35, 5 months 23 days ago

NanoViricides dévoile un agent antiviral révolutionnaire à large spectre

NV-387 Essais Cliniques Antiviral Nanomédecine À Large Spectre
BRIEF

published on 05/29/2024 at 12:35, 5 months 23 days ago

NanoViricides Unveils Revolutionary Broad-Spectrum Antiviral Agent

NV-387 Clinical Trials Antiviral Nanomedicine Broad-spectrum
PRESS RELEASE

published on 05/29/2024 at 12:30, 5 months 23 days ago

A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
NanoViricides, Inc. elaborates on its groundbreaking host-mimetic, broad-spectrum antiviral technology platform, NV-387, designed to revolutionize viral infection treatment with advanced decoy mechanisms

NV-387 NanoViricides Inc. Broad-spectrum Host-mimetic Technology Antiviral Agent
BRIEF

published on 05/23/2024 at 12:35, 5 months 29 days ago

NanoViricides renforce les efforts de partenariat - engage Aagami Inc.

NanoViricides NV-387 Partenariat Antiviral Aagami
BRIEF

published on 05/23/2024 at 12:35, 5 months 29 days ago

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.

NanoViricides NV-387 Partnership Antiviral Aagami
PRESS RELEASE

published on 05/23/2024 at 12:30, 5 months 29 days ago

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
NanoViricides, Inc. engages Aagami, Inc. to seek licensing and partnering opportunities for its antiviral nanomedicines including key asset NV-387. Aagami to focus on India and Japan

NV-387 NanoViricides Inc. Antiviral Nanomedicines Aagami Inc. Licensing And Partnering Opportunities

Accesswire

Published on 11/22/2024 at 00:00, 8 hours 35 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 10 hours 30 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 10 hours 45 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 12 hours 20 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 12 hours 25 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 08:12, 23 minutes ago

EQS-Adhoc: PVA TePla AG launches share buyback program to support strategic acquisitions and long-term compensation plans
Published on 11/22/2024 at 08:09, 25 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 08:00, 35 minutes ago

Q3 Trading Update
Published on 11/22/2024 at 08:00, 35 minutes ago

Addition of Mr Alain Nydegger as an Eligible Participant under the Group’s Matching Share Plan 2025-2028
Published on 11/22/2024 at 08:00, 35 minutes ago

NOTICE OF EXTRAORDINARY GENERAL MEETING OF MULTITUDE P.L.C.

Les Echos

Published on 11/21/2024 at 06:58, 1 day 1 hour ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 1 hour ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 1 hour ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 12 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 13 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE